<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073811424796</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073811424796</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Topical Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Algorithmic Approach for Methyl-CpG Binding Protein 2 (<italic>MECP2</italic>) Gene Testing in Patients With Neurodevelopmental Disabilities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sanmann</surname>
<given-names>Jennifer N.</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-0883073811424796">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073811424796"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaefer</surname>
<given-names>G. Bradley</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073811424796">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buehler</surname>
<given-names>Bruce A.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0883073811424796">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanger</surname>
<given-names>Warren G.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073811424796">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883073811424796">
<label>1</label>Human Genetics Laboratories, University of Nebraska Medical Center and the Munroe-Meyer Institute for Genetics and Rehabilitation, Omaha, NE, USA</aff>
<aff id="aff2-0883073811424796">
<label>2</label>Division of Medical Genetics, University of Arkansas for Medical Sciences and Arkansas Children’s Hospital, Little Rock, AK, USA</aff>
<aff id="aff3-0883073811424796">
<label>3</label>Genetic Medicine, University of Nebraska Medical Center and the Munroe-Meyer Institute for Genetics and Rehabilitation, Omaha, NE, USA</aff>
<author-notes>
<corresp id="corresp1-0883073811424796">Jennifer Sanmann, MS, Human Genetics Laboratories, University of Nebraska Medical Center and the Munroe-Meyer Institute for Genetics and Rehabilitation, 985440 Nebraska Medical Center, Omaha, NE 68198-5440, USA Email: <email>jsanmann@unmc.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>3</issue>
<fpage>346</fpage>
<lpage>354</lpage>
<history>
<date date-type="received">
<day>3</day>
<month>8</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>1</day>
<month>9</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>9</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Methyl-CpG binding protein 2 gene (<italic>MECP2</italic>) testing is indicated for patients with numerous clinical presentations, including Rett syndrome (classic and atypical), unexplained neonatal encephalopathy, Angelman syndrome, nonspecific mental retardation, autism (females), and an X-linked family history of developmental delay. Because of this complexity, a gender-specific approach for comprehensive<italic> MECP2</italic> gene testing is described. Briefly, sequencing of exons 1 to 4 of <italic>MECP2</italic> is recommended for patients with a Rett syndrome phenotype, unexplained neonatal encephalopathy, an Angelman syndrome phenotype (with negative 15q11-13 analysis), nonspecific mental retardation, or autism (females). Additional testing for large-scale <italic>MECP2</italic> deletions is recommended for patients with Rett syndrome or Angelman syndrome phenotypes (with negative 15q11-13 analysis) following negative sequencing. Alternatively, testing for large-scale <italic>MECP2</italic> duplications is recommended for males presenting with mental retardation, an X-linked family history of developmental delay, and a significant proportion of previously described clinical features (particularly a history of recurrent respiratory infections).</p>
</abstract>
<kwd-group>
<kwd>methyl-CpG binding protein 2 (<italic>MECP2</italic>)</kwd>
<kwd>Rett syndrome</kwd>
<kwd>Angelman syndrome</kwd>
<kwd>neonatal encephalopathy</kwd>
<kwd>deletion/duplication</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0883073811424796">
<title>
<italic>MECP2 </italic>Structure and Function In Vivo</title>
<p>The methyl-CpG binding protein 2 (MeCP2) is encoded by <italic>MECP2</italic> (OMIM 300005), which is an approximately 76-kilobase gene that maps to Xq28.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811424796">1</xref>
<xref ref-type="bibr" rid="bibr2-0883073811424796"/>
<xref ref-type="bibr" rid="bibr3-0883073811424796"/>–<xref ref-type="bibr" rid="bibr4-0883073811424796">4</xref>
</sup> <italic>MECP2</italic> is encoded by 4 exons that give rise to 2 isoforms, <italic>MECP2e2</italic> and <italic>MECP2e1</italic>. These 2 isoforms are encoded by exons 2, 3, and 4 and by exons 1, 3, and 4, respectively.<sup>
<xref ref-type="bibr" rid="bibr5-0883073811424796">5</xref>
</sup> This protein contains 4 significant domains, including a methyl binding domain, a transcription repression domain, a nuclear localization signal, and a carboxyl terminal domain (<xref ref-type="table" rid="table1-0883073811424796">Table 1</xref>).<sup>
<xref ref-type="bibr" rid="bibr6-0883073811424796">6</xref>
<xref ref-type="bibr" rid="bibr7-0883073811424796"/>
<xref ref-type="bibr" rid="bibr8-0883073811424796"/>
<xref ref-type="bibr" rid="bibr9-0883073811424796"/>
<xref ref-type="bibr" rid="bibr10-0883073811424796"/>
<xref ref-type="bibr" rid="bibr11-0883073811424796"/>–<xref ref-type="bibr" rid="bibr12-0883073811424796">12</xref>
</sup>
</p>
<table-wrap id="table1-0883073811424796" position="float">
<label>Table 1.</label>
<caption>
<p>Characteristics of the Functional Domains of the Methyl-CpG Binding Protein 2</p>
</caption>
<graphic alternate-form-of="table1-0883073811424796" xlink:href="10.1177_0883073811424796-table1.tif"/>
<table>
<thead>
<tr>
<th>Domain</th>
<th>Domain Function</th>
<th>Residues</th>
<th>Exon(s)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Methyl binding domain</td>
<td>Essential for the binding of MeCP2 to methylated CpG dinucleotides<sup>
<xref ref-type="bibr" rid="bibr6-0883073811424796">6</xref>,<xref ref-type="bibr" rid="bibr7-0883073811424796">7</xref>
</sup>
</td>
<td>78-162</td>
<td>3 and 4</td>
</tr>
<tr>
<td>Transcription repression domain</td>
<td>Interacts with the co-repressor <italic>SIN3A</italic> to recruit histone deacetylases for transcription repression<sup>
<xref ref-type="bibr" rid="bibr8-0883073811424796">8</xref>,<xref ref-type="bibr" rid="bibr9-0883073811424796">9</xref>
</sup>
</td>
<td>207-310</td>
<td>4</td>
</tr>
<tr>
<td>Nuclear localization signal</td>
<td>Mediates the transport of MeCP2 to the nucleus<sup>
<xref ref-type="bibr" rid="bibr10-0883073811424796">10</xref>,<xref ref-type="bibr" rid="bibr11-0883073811424796">11</xref>
</sup>
</td>
<td>255-271</td>
<td>4</td>
</tr>
<tr>
<td>Carboxyl terminal domain</td>
<td>Aids binding to the nucleosome core<sup>
<xref ref-type="bibr" rid="bibr12-0883073811424796">12</xref>
</sup>
</td>
<td>310-486</td>
<td>4</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0883073811424796">
<p>MeCP2, methyl-CpG binding protein 2; CpG, cytosine-phosphate-guanine.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>
<italic>MECP2</italic> expression is ubiquitous throughout the body, but of particular importance is its expression in mature postmigratory neurons.<sup>
<xref ref-type="bibr" rid="bibr13-0883073811424796">13</xref>
</sup> MeCP2 binds specifically to methylated cytosine-phosphate-guanine (CpG) dinucleotides and acts as a global transcriptional repressor. To date, the transcriptional targets of MeCP2 are not fully understood. However, genes involved in neuronal development and survival (<italic>BDNF</italic>
<sup>
<xref ref-type="bibr" rid="bibr14-0883073811424796">14</xref>
<xref ref-type="bibr" rid="bibr15-0883073811424796"/>
<xref ref-type="bibr" rid="bibr16-0883073811424796"/>–<xref ref-type="bibr" rid="bibr17-0883073811424796">17</xref>
</sup>), neuronal repression (xHairy2a<sup>
<xref ref-type="bibr" rid="bibr18-0883073811424796">18</xref>
</sup>), neuronal transcription factors (<italic>DLX5</italic>/Dlx5<sup>
<xref ref-type="bibr" rid="bibr19-0883073811424796">19</xref>
</sup> and <italic>ID1-3</italic>/Id1-3<sup>
<xref ref-type="bibr" rid="bibr20-0883073811424796">20</xref>
</sup>), hormone signaling (<italic>SGK1</italic> and <italic>FKBP5</italic>
<sup>
<xref ref-type="bibr" rid="bibr21-0883073811424796">21</xref>
</sup> and <italic>IGFBP3</italic>/Igfbp3<sup>
<xref ref-type="bibr" rid="bibr22-0883073811424796">22</xref>
</sup>), the mitochondrial respiratory chain (<italic>UQCRC1</italic>
<sup>
<xref ref-type="bibr" rid="bibr23-0883073811424796">23</xref>
</sup>), and ion channel regulation (<italic>FXYD1</italic>/Fxyd1<sup>
<xref ref-type="bibr" rid="bibr24-0883073811424796">24</xref>
</sup>) are reported potential targets. In addition, genes acting as neuropeptides (CRH<sup>
<xref ref-type="bibr" rid="bibr25-0883073811424796">25</xref>
</sup>), ubiquitin ligases (<italic>UBE3A</italic>
<sup>
<xref ref-type="bibr" rid="bibr26-0883073811424796">26</xref>
</sup>), and γ-aminobutyric acid type A (GABA-A) receptors (<italic>GABRB3</italic>
<sup>
<xref ref-type="bibr" rid="bibr26-0883073811424796">26</xref>
</sup>) have been implicated as potential targets in the literature.<sup>
<xref ref-type="bibr" rid="bibr27-0883073811424796">27</xref>
</sup>
</p>
</sec>
<sec id="section2-0883073811424796">
<title>Clinical Presentations Associated With <italic>MECP2</italic> Mutations</title>
<sec id="section3-0883073811424796">
<title>Rett Syndrome</title>
<p>Rett syndrome is a relatively common genetic cause of mental retardation, which affects approximately 1/10 000 to 15 000 females and, albeit extremely rarely, males (most commonly those males with X-chromosome aneuploidy).<sup>
<xref ref-type="bibr" rid="bibr28-0883073811424796">28</xref>
<xref ref-type="bibr" rid="bibr29-0883073811424796"/>
<xref ref-type="bibr" rid="bibr30-0883073811424796"/>
<xref ref-type="bibr" rid="bibr31-0883073811424796"/>
<xref ref-type="bibr" rid="bibr32-0883073811424796"/>
<xref ref-type="bibr" rid="bibr33-0883073811424796"/>
<xref ref-type="bibr" rid="bibr34-0883073811424796"/>
<xref ref-type="bibr" rid="bibr35-0883073811424796"/>
<xref ref-type="bibr" rid="bibr36-0883073811424796"/>–<xref ref-type="bibr" rid="bibr37-0883073811424796">37</xref>
</sup> This syndrome was first described by Andreas Rett in 1966 and follows an X-linked dominant inheritance pattern.<sup>
<xref ref-type="bibr" rid="bibr38-0883073811424796">38</xref>
</sup> The clinical hallmarks of Rett syndrome include normal development until approximately 6 to 18 months of life, followed by a subsequent slowing of neurological development and regression of fine motor and communication skills, microcephaly, seizures, autistic behaviors, ataxia, and stereotypic hand movements.<sup>
<xref ref-type="bibr" rid="bibr38-0883073811424796">38</xref>
<xref ref-type="bibr" rid="bibr39-0883073811424796"/>–<xref ref-type="bibr" rid="bibr40-0883073811424796">40</xref>
</sup> Individuals diagnosed with Rett syndrome in the clinical setting can be categorized as having classic or atypical Rett syndrome, based on their clinical presentations.<sup>
<xref ref-type="bibr" rid="bibr41-0883073811424796">41</xref>
</sup>
</p>
<sec id="section4-0883073811424796">
<title>Females with Rett syndrome</title>
<p>Approximately 80% of females with Rett syndrome have a sequence mutation in <italic>MECP2</italic>.<sup>
<xref ref-type="bibr" rid="bibr42-0883073811424796">42</xref>
<xref ref-type="bibr" rid="bibr43-0883073811424796"/>
<xref ref-type="bibr" rid="bibr44-0883073811424796"/>–<xref ref-type="bibr" rid="bibr45-0883073811424796">45</xref>
</sup> The recurrent types of mutations identified by polymerase chain reaction–based sequencing (missense, nonsense, and deletions) exhibit MeCP2 domain specificity and each type comprises 13% to 35% of the total number of <italic>MECP2</italic> sequence mutations (<xref ref-type="table" rid="table2-0883073811424796">Table 2</xref>).<sup>
<xref ref-type="bibr" rid="bibr42-0883073811424796">42</xref>,<xref ref-type="bibr" rid="bibr44-0883073811424796">44</xref>
<xref ref-type="bibr" rid="bibr45-0883073811424796"/>
<xref ref-type="bibr" rid="bibr46-0883073811424796"/>
<xref ref-type="bibr" rid="bibr47-0883073811424796"/>
<xref ref-type="bibr" rid="bibr48-0883073811424796"/>
<xref ref-type="bibr" rid="bibr49-0883073811424796"/>
<xref ref-type="bibr" rid="bibr50-0883073811424796"/>–<xref ref-type="bibr" rid="bibr51-0883073811424796">51</xref>
</sup> Approximately 90% of <italic>MECP2</italic> mutations cluster in exon 4, whereas ∼7% are found in exon 3.<sup>
<xref ref-type="bibr" rid="bibr49-0883073811424796">49</xref>
</sup> Regardless of location within <italic>MECP2</italic>, the most frequent type of mutation seen in patients with Rett syndrome is a single nucleotide change, which accounts for approximately 80% of the currently described <italic>MECP2</italic> mutations.<sup>47,<xref ref-type="bibr" rid="bibr49-0883073811424796">49</xref>,<xref ref-type="bibr" rid="bibr50-0883073811424796">50</xref>,<xref ref-type="bibr" rid="bibr52-0883073811424796">52</xref>,<xref ref-type="bibr" rid="bibr53-0883073811424796">53</xref>
</sup> Specifically, cytosine to thymine (C&gt;T) nucleotide changes comprise nearly 65% of all described <italic>MECP2</italic> mutations, with the alteration of arginine (CGA) to a premature stop codon (TGC) being the most common.<sup>
<xref ref-type="bibr" rid="bibr50-0883073811424796">50</xref>
<xref ref-type="bibr" rid="bibr51-0883073811424796"/>–<xref ref-type="bibr" rid="bibr52-0883073811424796">52</xref>,<xref ref-type="bibr" rid="bibr54-0883073811424796">54</xref>,<xref ref-type="bibr" rid="bibr55-0883073811424796">55</xref>
</sup>
</p>
<p>In addition to sequence mutations, recent studies have identified gross rearrangements of the <italic>MECP2</italic> gene in both classic and atypical female patients with Rett syndrome. Nearly 80% of the reported cases with large-scale deletions in <italic>MECP2</italic> meet clinical standards for classic Rett syndrome; the remaining 20% of patients are clinically characterized as presenting with atypical Rett syndrome. In addition, of the patients with Rett syndrome studied who are mutation-negative by traditional polymerase chain reaction–based sequencing, approximately 32% of classic and 6.5% of atypical patients have a deletion of the <italic>MECP2</italic> gene.<sup>
<xref ref-type="bibr" rid="bibr45-0883073811424796">45</xref>,<xref ref-type="bibr" rid="bibr48-0883073811424796">48</xref>,<xref ref-type="bibr" rid="bibr56-0883073811424796">56</xref>
<xref ref-type="bibr" rid="bibr57-0883073811424796"/>
<xref ref-type="bibr" rid="bibr58-0883073811424796"/>
<xref ref-type="bibr" rid="bibr59-0883073811424796"/>
<xref ref-type="bibr" rid="bibr60-0883073811424796"/>
<xref ref-type="bibr" rid="bibr61-0883073811424796"/>
<xref ref-type="bibr" rid="bibr62-0883073811424796"/>
<xref ref-type="bibr" rid="bibr63-0883073811424796"/>
<xref ref-type="bibr" rid="bibr64-0883073811424796"/>–<xref ref-type="bibr" rid="bibr65-0883073811424796">65</xref>
</sup> Although these deletions vary in size and location within the gene, they most commonly include exons 3 to 4 of <italic>MECP2</italic>. Although not all studies included informative data, the large-scale deletions identified in 17 reported cases extend into interleukin-1 receptor-associated kinase (<italic>IRAK1;</italic> OMIM 300283) located approximately 0.04 megabases centromeric to <italic>MECP2</italic>.<sup>
<xref ref-type="bibr" rid="bibr60-0883073811424796">60</xref>,<xref ref-type="bibr" rid="bibr62-0883073811424796">62</xref>
<xref ref-type="bibr" rid="bibr63-0883073811424796"/>
<xref ref-type="bibr" rid="bibr64-0883073811424796"/>–<xref ref-type="bibr" rid="bibr65-0883073811424796">65</xref>
</sup> The phenotypes of these individuals were not noted to be more or less severe than those without the <italic>IRAK1</italic> deletions. Interestingly, female patients who are monosomy for the distal portion of Xq typically have a normal physical phenotype but often have premature ovarian failure.<sup>
<xref ref-type="bibr" rid="bibr66-0883073811424796">66</xref>
<xref ref-type="bibr" rid="bibr67-0883073811424796"/>
<xref ref-type="bibr" rid="bibr68-0883073811424796"/>
<xref ref-type="bibr" rid="bibr69-0883073811424796"/>
<xref ref-type="bibr" rid="bibr70-0883073811424796"/>–<xref ref-type="bibr" rid="bibr71-0883073811424796">71</xref>
</sup> These deletions typically span the Xq26-Xqter regions, and the gene responsible for premature ovarian failure has now been localized between the Xq27.2/Xq27.3 and Xqter regions.<sup>
<xref ref-type="bibr" rid="bibr72-0883073811424796">72</xref>
</sup> Presumably, because the entire <italic>MECP2</italic> gene and its regulatory elements are absent, these mega-deletions do not result in the Rett syndrome phenotype associated with more localized, smaller-scale <italic>MECP2</italic> deletions that lead to an altered MeCP2 protein product.</p>
<table-wrap id="table2-0883073811424796" position="float">
<label>Table 2.</label>
<caption>
<p>Summary of Sequencing Mutations in <italic>MECP2</italic> Identified in Female Patients With Rett Syndrome</p>
</caption>
<graphic alternate-form-of="table2-0883073811424796" xlink:href="10.1177_0883073811424796-table2.tif"/>
<table>
<thead>
<tr>
<th>Type of Mutation</th>
<th>Domain</th>
<th>Percentage of Total</th>
</tr>
</thead>
<tbody>
<tr>
<td>Missense</td>
<td>MBD</td>
<td>35</td>
</tr>
<tr>
<td>Nonsense</td>
<td>MBD and TRD, TRD alone</td>
<td>48</td>
</tr>
<tr>
<td>Small-scale deletions</td>
<td>CTD</td>
<td>13-30</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0883073811424796">
<p>CTD, carboxyl terminal domain; MBD, methyl binding domain; <italic>MECP2</italic>, methyl-CpG binding protein 2; TRD, transcription repression domain.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section5-0883073811424796">
<title>Males with Rett syndrome</title>
<p>As previously mentioned, studies have shown that sequence mutations of <italic>MECP2</italic> are a cause of classic Rett syndrome in males. Alternatively, severe neonatal-onset encephalopathy has been identified in male patients with<italic> MECP2</italic> mutations. Sequence mutations in the methyl binding domain of <italic>MECP2</italic> are most commonly found in males presenting with a Rett syndrome or Rett syndrome–like phenotype who also have X-chromosome aneuploidy.<sup>
<xref ref-type="bibr" rid="bibr34-0883073811424796">34</xref>,<xref ref-type="bibr" rid="bibr73-0883073811424796">73</xref>
<xref ref-type="bibr" rid="bibr74-0883073811424796"/>–<xref ref-type="bibr" rid="bibr75-0883073811424796">75</xref>
</sup> Conversely, mutations in the transcription repression domain of <italic>MECP2</italic> are most commonly found in males presenting with severe neonatal-onset encephalopathy, microcephaly, dystonia, involuntary movements, severe seizures, and prominent breathing abnormalities without documented mosaicism.<sup>
<xref ref-type="bibr" rid="bibr33-0883073811424796">33</xref>,76-<xref ref-type="bibr" rid="bibr78-0883073811424796">78</xref>
</sup> These <italic>MECP2 </italic>sequence mutations have been characterized as causative because they have also been identified in female patients with Rett syndrome.<sup>
<xref ref-type="bibr" rid="bibr30-0883073811424796">30</xref>
<xref ref-type="bibr" rid="bibr31-0883073811424796"/>
<xref ref-type="bibr" rid="bibr32-0883073811424796"/>
<xref ref-type="bibr" rid="bibr33-0883073811424796"/>
<xref ref-type="bibr" rid="bibr34-0883073811424796"/>
<xref ref-type="bibr" rid="bibr35-0883073811424796"/>
<xref ref-type="bibr" rid="bibr36-0883073811424796"/>–<xref ref-type="bibr" rid="bibr37-0883073811424796">37</xref>,<xref ref-type="bibr" rid="bibr74-0883073811424796">74</xref>
<xref ref-type="bibr" rid="bibr75-0883073811424796"/>
<xref ref-type="bibr" rid="bibr76-0883073811424796"/>
<xref ref-type="bibr" rid="bibr77-0883073811424796"/>
<xref ref-type="bibr" rid="bibr78-0883073811424796"/>
<xref ref-type="bibr" rid="bibr79-0883073811424796"/>
<xref ref-type="bibr" rid="bibr80-0883073811424796"/>
<xref ref-type="bibr" rid="bibr81-0883073811424796"/>
<xref ref-type="bibr" rid="bibr82-0883073811424796"/>–<xref ref-type="bibr" rid="bibr83-0883073811424796">83</xref>
</sup> However, a number of reported <italic>MECP2</italic> sequence mutations identified in male patients with nonspecific mental retardation have not been identified in a clinically affected female population.<sup>29,36,75,80,81,83-85</sup> In addition, mutations identified in seemingly affected males have been reported in apparently unaffected females with random X-chromosome inactivation.<sup>
<xref ref-type="bibr" rid="bibr29-0883073811424796">29</xref>,<xref ref-type="bibr" rid="bibr84-0883073811424796">84</xref>-86</sup> Therefore, the pathogenicity of these mutations has not been established. As the number of male patients sequenced for <italic>MECP2</italic> increases and knowledge about these mutations expands, these unclassified variants will be more accurately delineated as causative mutations or benign polymorphic variants.</p>
<p>In addition to sequence mutations, Hardwick et al<sup>
<xref ref-type="bibr" rid="bibr65-0883073811424796">65</xref>
</sup> detected a male patient with neonatal encephalopathy and a deletion of exons 3 and 4 of <italic>MECP2</italic>. This patient also had an affected sister with classic Rett syndrome and a typical X-inactivation pattern (52:48) and an affected mother with mild learning disabilities and a skewed X-inactivation (93:7). Therefore, large-scale deletions can be a cause of neonatal encephalopathy in males and should be considered in light of this familial case report.</p>
</sec>
<sec id="section6-0883073811424796">
<title>Angelman Syndrome</title>
<p>
<italic>MECP2</italic> mutations have also been reported in patients with a phenotype similar to that of Angelman syndrome. In fact, some speak of a Rett-Angelman syndrome spectrum.<sup>
<xref ref-type="bibr" rid="bibr87-0883073811424796">87</xref>
</sup> Like Rett syndrome, Angelman syndrome is a neurodevelopmental disorder characterized by severe mental retardation, absent speech, ataxia, seizures, and dysmorphic features. A genetic abnormality of chromosome 15q11-13 accounts for nearly 85% of Angelman syndrome patients, whereas the remaining ∼15% do not have an identifiable etiology.<sup>
<xref ref-type="bibr" rid="bibr88-0883073811424796">88</xref>,<xref ref-type="bibr" rid="bibr89-0883073811424796">89</xref>
</sup> In 2 studies, patients with a clinical diagnosis of Angelman syndrome and no abnormality of 15q11-13 were screened for sequence mutations in the <italic>MECP2</italic> gene.<sup>
<xref ref-type="bibr" rid="bibr75-0883073811424796">75</xref>,<xref ref-type="bibr" rid="bibr88-0883073811424796">88</xref>
</sup> From the 110 Angelman syndrome patients included in these 2 studies, <italic>MECP2</italic> mutations were identified in 7 patients (2 males and 5 females).<sup>
<xref ref-type="bibr" rid="bibr75-0883073811424796">75</xref>,<xref ref-type="bibr" rid="bibr88-0883073811424796">88</xref>
</sup> A period of regression was subsequently identified in a subset of these patients, and these individuals were therefore classified as having Rett syndrome. However, a number of patients were still considered clinically to have an Angelman syndrome–like phenotype with an <italic>MECP2</italic> mutation.</p>
</sec>
<sec id="section7-0883073811424796">
<title>Nonspecific Mental Retardation</title>
<p>
<italic>MECP2</italic> sequence mutations have been identified in both male and female patients with nonsyndromic cognitive defects.<sup>
<xref ref-type="bibr" rid="bibr55-0883073811424796">55</xref>,<xref ref-type="bibr" rid="bibr75-0883073811424796">75</xref>,<xref ref-type="bibr" rid="bibr84-0883073811424796">84</xref>-86,<xref ref-type="bibr" rid="bibr90-0883073811424796">90</xref>-93</sup> The estimated frequency of <italic>MECP2 </italic>mutations in this cohort ranges from 0.2% to 2%.<sup>
<xref ref-type="bibr" rid="bibr85-0883073811424796">85</xref>,<xref ref-type="bibr" rid="bibr90-0883073811424796">90</xref>
</sup> Interestingly, a study aimed at analyzing the number of exon 1 sequencing mutations in a cohort of 554 female and 200 male patients with nonspecific developmental delay/mental retardation identified 4 female but no male patients with an exon 1 mutation.<sup>93</sup> Although these results do not eliminate the possibility that males with nonspecific mental retardation may have mutations in exon 1, they do highlight the importance of exon 1 sequence analysis in female patients with nonspecific mental retardation, including those patients whose diagnostic <italic>MECP2</italic> sequence analysis was performed prior to the discovery of the current exon 1 of <italic>MECP2 </italic>in 2000.<sup>
<xref ref-type="bibr" rid="bibr5-0883073811424796">5</xref>
</sup>
</p>
</sec>
<sec id="section8-0883073811424796">
<title>Autism</title>
<p>In addition to Rett syndrome, Angelman syndrome, and nonspecific mental retardation, autism is another genetic neurodevelopmental disorder that has been associated with sequence-based mutations of <italic>MECP2</italic>. Autism is a complex genetic neurodevelopmental disorder characterized by extreme social and communicative difficulties and patterns of behavior that are restricted and/or stereotypic.<sup>
<xref ref-type="bibr" rid="bibr26-0883073811424796">26</xref>,<xref ref-type="bibr" rid="bibr94-0883073811424796">94</xref>
</sup> Several studies have identified female patients with autism and <italic>MECP2</italic> mutations; these mutations include both a small number of novel deleterious mutations and a majority of Rett syndrome–associated mutations.<sup>
<xref ref-type="bibr" rid="bibr95-0883073811424796">95</xref>
<xref ref-type="bibr" rid="bibr96-0883073811424796"/>
<xref ref-type="bibr" rid="bibr97-0883073811424796"/>
<xref ref-type="bibr" rid="bibr98-0883073811424796"/>–<xref ref-type="bibr" rid="bibr99-0883073811424796">99</xref>
</sup> The reported incidence of <italic>MECP2</italic> mutations in patients with autism is 3% to 13%.<sup>
<xref ref-type="bibr" rid="bibr96-0883073811424796">96</xref>,<xref ref-type="bibr" rid="bibr100-0883073811424796">100</xref>
</sup>
</p>
<p>As with previously discussed differential diagnoses, the majority of the sequence mutations identified in patients with autism (primarily female) are found in the coding region of <italic>MECP2</italic>. To date, only one likely pathogenic sequence mutation in <italic>MECP2</italic> (guanine to cytosine substitution at base 617; c.617G&gt;C) has been reported in a male with autism.<sup>
<xref ref-type="bibr" rid="bibr99-0883073811424796">99</xref>
</sup> However, a few studies have also analyzed the 3′-untranslated region in patients with autism and have found that, despite the high innate sequence variability, this region also contains significant sequence alterations identified primarily in the population of males with autism.<sup>
<xref ref-type="bibr" rid="bibr98-0883073811424796">98</xref>,<xref ref-type="bibr" rid="bibr99-0883073811424796">99</xref>
</sup> Specifically, a total of 14 variants were identified in this region, of which at least 7 were in conserved nucleotides.<sup>
<xref ref-type="bibr" rid="bibr98-0883073811424796">98</xref>,<xref ref-type="bibr" rid="bibr99-0883073811424796">99</xref>
</sup> Further studies performed on 4 of the male patients with autism and changes in conserved nucleotides of the 3′-untranslated region identified significantly lower <italic>MECP2</italic> mRNA levels as compared to normal male controls selected based on their absence of <italic>MECP2</italic> sequence mutations.<sup>
<xref ref-type="bibr" rid="bibr99-0883073811424796">99</xref>
</sup> As mentioned above, only 1 male patient with autism has been identified with a sequence-based mutation of <italic>MECP2</italic> in the coding region; however, based on these studies of the 3′-untranslated region, it is plausible that analysis of this region will be more significant for this cohort of patients in the future. It is necessary to perform analysis of the 3′-untranslated region on a number of male and female patients with a variety of other indications associated with <italic>MECP2</italic> sequence mutations (ie, Rett syndrome, Angelman syndrome, nonspecific mental retardation) before this specific population (males with autism) is considered exclusively for these mutations. In addition, studying an increased number of unaffected controls will be useful in determining the significance of mutations found in this highly variable region. Therefore, although current literature does not support clinical testing of male patients with autism for <italic>MECP2</italic> mutations, this cohort of patients should be closely monitored, as continued research may elucidate the necessity for testing in the future.</p>
</sec>
<sec id="section9-0883073811424796">
<title>Cerebral Palsy</title>
<p>Last, cerebral palsy is a clinical diagnosis used to describe patients with impaired control of their movements due to a defect in the developing brain, which does not worsen over time.<sup>
<xref ref-type="bibr" rid="bibr101-0883073811424796">101</xref>
</sup> For the purposes of this article, cerebral palsy will be defined as a static encephalopathy with spasticity that is not otherwise explained. These individuals may also present with a number of additional conditions, including, but not limited to, mental retardation, ataxia, abnormal gait, and seizures. One important physical clue can be the presence of “silver-gray” hair in males with cerebral palsy and <italic>MECP2</italic> mutations. Although historically associated with brain injury, a variety of scientific studies have strongly suggested a genetic basis for a portion of the population with cerebral palsy.<sup>
<xref ref-type="bibr" rid="bibr102-0883073811424796">102</xref>
<xref ref-type="bibr" rid="bibr103-0883073811424796"/>
<xref ref-type="bibr" rid="bibr104-0883073811424796"/>
<xref ref-type="bibr" rid="bibr105-0883073811424796"/>
<xref ref-type="bibr" rid="bibr106-0883073811424796"/>–<xref ref-type="bibr" rid="bibr107-0883073811424796">107</xref>
</sup> Based on the emerging strong evidence for genetic etiologies of cerebral palsy and the prevalence of <italic>MECP2</italic> mutations in a variety of clinically abnormal phenotypes, polymerase chain reaction–based sequencing of the <italic>MECP2</italic> gene is recommended for part of the etiologic evaluation in patients diagnosed with cerebral palsy.<sup>
<xref ref-type="bibr" rid="bibr108-0883073811424796">108</xref>
</sup>
</p>
</sec>
<sec id="section10-0883073811424796">
<title>
<italic>MECP2</italic> Duplication</title>
<p>The mutations historically associated with <italic>MECP2</italic> are loss-of-function mutations. Therefore, in an effort to investigate the therapeutic feasibility of enhancing endogenous MeCP2 or introducing a wild-type MeCP2 using gene therapy in patients with Rett syndrome, a mouse model was developed that transgenically expressed MeCP2 under the endogenous human promoter.<sup>
<xref ref-type="bibr" rid="bibr109-0883073811424796">109</xref>
</sup> Interestingly, the results of this study demonstrated that even modest levels of excess MeCP2 can cause a progressive neurological phenotype.<sup>
<xref ref-type="bibr" rid="bibr109-0883073811424796">109</xref>
</sup>
</p>
<p>Large-scale duplications of <italic>MECP2</italic> have been identified in a population of male patients with distinguishable clinical findings, including a history of recurrent respiratory infections, intellectual disability, limited/lack of speech, limited/lack of ambulation, hypotonia, swallowing dysfunction, and seizures.<sup>
<xref ref-type="bibr" rid="bibr110-0883073811424796">110</xref>
<xref ref-type="bibr" rid="bibr111-0883073811424796"/>
<xref ref-type="bibr" rid="bibr112-0883073811424796"/>
<xref ref-type="bibr" rid="bibr113-0883073811424796"/>
<xref ref-type="bibr" rid="bibr114-0883073811424796"/>–<xref ref-type="bibr" rid="bibr115-0883073811424796">115</xref>
</sup> Approximately ∼80% of reported cases describe a history of recurrent respiratory infections, and this finding may prove to be one of the key factors in distinguishing this group of patients from the large number of other known autosomal and X-linked syndromes. Before testing such as multiplex ligation-dependent probe amplification was available, disomy of the distal Xq region was observed in a number of patients closely matching the clinical features described in these mutations now attributed specifically to duplication of <italic>MECP2</italic> at Xq28, including microcephaly, developmental delay/mental retardation, hypotonia, hypertelorism, and recurrent respiratory infections.<sup>
<xref ref-type="bibr" rid="bibr66-0883073811424796">66</xref>,<xref ref-type="bibr" rid="bibr116-0883073811424796">116</xref>
<xref ref-type="bibr" rid="bibr117-0883073811424796"/>
<xref ref-type="bibr" rid="bibr118-0883073811424796"/>
<xref ref-type="bibr" rid="bibr119-0883073811424796"/>
<xref ref-type="bibr" rid="bibr120-0883073811424796"/>
<xref ref-type="bibr" rid="bibr121-0883073811424796"/>–<xref ref-type="bibr" rid="bibr122-0883073811424796">122</xref>
</sup>
</p>
<p>Duplications in the Xq28 region range in size from 0.2 to 2.3 megabases.<sup>
<xref ref-type="bibr" rid="bibr110-0883073811424796">110</xref>,<xref ref-type="bibr" rid="bibr112-0883073811424796">112</xref>,<xref ref-type="bibr" rid="bibr113-0883073811424796">113</xref>
</sup> The most common duplicated region includes both the <italic>MECP2</italic> and <italic>L1CAM</italic> (L1 cell adhesion molecule; OMIM 308840) genes. However, the critical gene in this group of male patients seems to be the <italic>MECP2</italic> gene, as there are reported patients with the appropriate clinical presentation and duplication of <italic>MECP2</italic> without duplication of <italic>L1CAM</italic>.<sup>
<xref ref-type="bibr" rid="bibr111-0883073811424796">111</xref>,<xref ref-type="bibr" rid="bibr113-0883073811424796">113</xref>
</sup> Studies to date do not clearly indicate whether the size of the duplication or the inclusion of the <italic>L1CAM</italic> gene region influences the severity of the phenotype. One report of a triplication of <italic>MECP2</italic> resulted in a more severe phenotype than in patients with <italic>MECP2</italic> duplications.<sup>
<xref ref-type="bibr" rid="bibr110-0883073811424796">110</xref>
</sup>
</p>
<p>In addition to the affected males with <italic>MECP2</italic> duplications, mothers and other female family members of these male patients have been shown to be carriers of the <italic>MECP2</italic> duplication.<sup>
<xref ref-type="bibr" rid="bibr110-0883073811424796">110</xref>,<xref ref-type="bibr" rid="bibr112-0883073811424796">112</xref>,<xref ref-type="bibr" rid="bibr113-0883073811424796">113</xref>
</sup> These female carriers are typically phenotypically normal and consistently have favorably skewed X-inactivation, likely minimizing the expression of the duplicated <italic>MECP2</italic> gene region. Therefore, although this <italic>MECP2</italic> duplication has little impact on the phenotype of female carriers, it will be an important factor in their reproductive genetic counseling.</p>
</sec>
</sec>
<sec id="section11-0883073811424796">
<title>Summary of Reported <italic>MECP2</italic> Mutations</title>
<p>A summary of reported<italic> MECP2</italic> mutations characterized by gender and phenotype is included in <xref ref-type="table" rid="table3-0883073811424796">Table 3</xref>. Specifically, <italic>MECP2</italic> sequence analysis is the highest yield genetic test to perform on patients with a suspected clinical diagnosis of Rett syndrome, as this analysis identifies a genetic etiology in ∼80% of suspected Rett syndrome cases. In addition, this testing has identified <italic>MECP2</italic> mutations in patients with differential diagnoses that include Angelman syndrome (without 15q11-13 abnormalities), autism (females), unexplained neonatal encephalopathy, and nonspecific mental retardation. Current literature also supports large-scale deletion testing of <italic>MECP2</italic> in the absence of an<italic> MECP2</italic> sequence mutation in patients with classic or atypical Rett syndrome phenotype, as the yield is ∼32% and ∼6.5%, respectively. No large-scale studies have been performed to assess the yield of large-scale deletion testing in <italic>MECP2</italic> sequence-negative patients with alternative testing indications (autism, nonspecific mental retardation, and cerebral palsy). Therefore, it will be critical to monitor the current literature and to include the large-scale deletion testing for these alternative clinical phenotypes if it is indicated in the future.</p>
<table-wrap id="table3-0883073811424796" position="float">
<label>Table 3.</label>
<caption>
<p>Reported Mutations in <italic>MECP2</italic> by Phenotype and Gender</p>
</caption>
<graphic alternate-form-of="table3-0883073811424796" xlink:href="10.1177_0883073811424796-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th colspan="2">Sequencing Mutation and/or Small-Scale Deletion</th>
<th colspan="2">Large-Scale Deletion</th>
<th colspan="2">Large-Scale Duplication</th>
</tr>
<tr>
<th>Phenotype</th>
<th>Female</th>
<th>Male</th>
<th>Female</th>
<th>Male</th>
<th>Female</th>
<th>Male</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rett syndrome</td>
<td>+</td>
<td>+<sup><xref ref-type="table-fn" rid="table-fn4-0883073811424796">a</xref></sup>
</td>
<td>+</td>
<td>−<sup><xref ref-type="table-fn" rid="table-fn5-0883073811424796">b</xref></sup>
</td>
<td align="center">–</td>
<td align="center">–</td>
</tr>
<tr>
<td>Static encephalopathy/cerebral palsy</td>
<td align="center">–</td>
<td>+</td>
<td align="center">–</td>
<td>+<sup><xref ref-type="table-fn" rid="table-fn5-0883073811424796">b</xref></sup>
</td>
<td align="center">–</td>
<td align="center">–</td>
</tr>
<tr>
<td>Angelman syndrome</td>
<td>+</td>
<td>+</td>
<td align="center">–</td>
<td align="center">–</td>
<td align="center">–</td>
<td align="center">–</td>
</tr>
<tr>
<td>Nonspecific mental retardation</td>
<td>+</td>
<td>+</td>
<td align="center">–</td>
<td align="center">–</td>
<td align="center">–</td>
<td align="center">–</td>
</tr>
<tr>
<td>Autism</td>
<td>+</td>
<td>+<sup><xref ref-type="table-fn" rid="table-fn6-0883073811424796">c</xref></sup>
</td>
<td align="center">–</td>
<td align="center">–</td>
<td align="center">–</td>
<td align="center">–</td>
</tr>
<tr>
<td>
<italic>MECP2</italic> duplication syndrome</td>
<td align="center">–</td>
<td align="center">–</td>
<td align="center">–</td>
<td align="center">–</td>
<td>–<sup><xref ref-type="table-fn" rid="table-fn7-0883073811424796">d</xref></sup>
</td>
<td>+</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn12-0883073811424796">
<p>
<italic>MECP2</italic>, methyl CpG-binding protein 2.</p>
</fn>
<fn id="table-fn4-0883073811424796">
<p>
<sup>a</sup>The majority of males with <italic>MECP2</italic> sequencing mutations exhibit X-chromosome aneuploidy.</p>
</fn>
<fn id="table-fn5-0883073811424796">
<p>
<sup>b</sup>Only 1 case has been reported to date.<sup><xref ref-type="bibr" rid="bibr65-0883073811424796">65</xref></sup>
</p>
</fn>
<fn id="table-fn6-0883073811424796">
<p>
<sup>c</sup>Only 1 likely pathogenic mutation has been reported to date.<sup>
<xref ref-type="bibr" rid="bibr99-0883073811424796">99</xref>
</sup>
</p>
</fn>
<fn id="table-fn7-0883073811424796">
<p>
<sup>d</sup>A large number of females have been reported with duplications of <italic>MECP2;</italic> however, these females exhibit an apparently normal phenotype, presumably as a result of favorable skewed X-chromosome inactivation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Although general disomy of the distal Xq has been reported in males over the past few decades, the gene responsible for the phenotype associated with these duplications has recently been identified as <italic>MECP2</italic>. A preliminary compilation of relevant clinical features has begun to emerge, including an X-linked family history of developmental delay and, notably, a history of recurrent respiratory infections. As this cohort of patients continues to grow, it will be critical to monitor the size of the duplication (including inclusion or exclusion of <italic>L1CAM</italic>) and the clinical presentation of the affected patients to further refine the genotype:phenotype correlation emerging in these individuals.</p>
</sec>
<sec id="section12-0883073811424796">
<title>Suggested Testing Algorithm for <italic>MECP2</italic>
</title>
<p>Based on current literature, testing of <italic>MECP2</italic> is indicated for a variety of clinical presentations, including Rett syndrome (classic and atypical), unexplained neonatal encephalopathy, Angelman syndrome, nonspecific mental retardation, autism (females), and an X-linked family history of developmental delay. Because of this complexity, a suggested approach for comprehensive<italic> MECP2</italic> gene testing is described for females and males in <xref ref-type="fig" rid="fig1-0883073811424796">Figure 1A</xref> and <xref ref-type="fig" rid="fig1-0883073811424796">1B</xref>, respectively.</p>
<fig id="fig1-0883073811424796" position="float">
<label>Figure 1.</label>
<caption>
<p>Recommended algorithm for <italic>MECP2</italic> testing in females (A) and in males (B). *One reported large-scale deletion with this clinical presentation to date.<sup>59</sup> **Consider testing if negative for 15q11-13 abnormality (including chromosome 15 methylation and <italic>UBE3A</italic> sequencing). RTT, Rett syndrome; PCR, polymerase chain reaction;<italic> MECP2</italic>, methyl CpG-binding protein 2; MLPA, multiplex ligation-dependent probe amplification; MR, mental retardation; FISH, fluorescence in situ hybridization; <italic>UBE3A</italic>, ubiquitin-protein ligase E3A.</p>
</caption>
<graphic alternate-form-of="fig1-0883073811424796" xlink:href="10.1177_0883073811424796-fig1.tif"/>
</fig>
<p>Briefly, as illustrated in the recommended algorithm, polymerase chain reaction–based sequencing of exons 1 to 4 of <italic>MECP2 </italic>should be offered to patients with a Rett syndrome (classic or atypical) phenotype, unexplained neonatal encephalopathy, an Angelman syndrome phenotype (with negative 15q11-13 analysis), nonspecific mental retardation, or autism (females). Additional testing for large-scale deletions of <italic>MECP2</italic> should be performed on patients with a Rett syndrome (classic or atypical) or an Angelman syndrome (with negative 15q11-13 analysis) phenotype when no sequence mutation is identified in <italic>MECP2</italic>. Patients with an Angelman syndrome–like phenotype are included in this large-scale deletion testing of <italic>MECP2</italic> because the clinical presentation of this cohort overlaps extensively with that of patients with Rett syndrome. Alternatively, when patients (male) present with developmental delay/mental retardation, an X-linked family history of developmental delay/mental retardation, and a significant proportion of the clinical features described (most notably a history of recurrent respiratory infections), testing for large-scale duplication (ie, fluorescence in situ hybridization, multiplex ligation-dependent probe amplification) of<italic> MECP2</italic> is indicated.</p>
</sec>
<sec id="section13-0883073811424796">
<title>Current Limitations</title>
<p>It is critical to note that this algorithm is limited by the testing currently available and therefore does not include testing for a variety of epigenetic factors, such as imprinting and methylation, or mRNA expression levels, which also may play a significant role in the normal function of MeCP2. As additional information about the structure, function, and interaction of <italic>MECP2</italic> with other genes becomes available, and as the availability of clinical testing continues to broaden, this algorithm can be modified to incorporate any new, relevant diagnostic testing. In addition, it is important to be mindful of new studies that may provide evidence for inclusion of other clinical phenotypes into the testing algorithm (ie, males with autism) or for expansion of the testing recommended for a particular clinical presentations (ie, large-scale deletion studies for females with autism).</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors thank Nicole Hackendahl for her technical assistance in preparing <xref ref-type="fig" rid="fig1-0883073811424796">Figure 1</xref> for publication according to the specification of this journal.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1-0883073811424796">
<p>All authors contributed significantly to the conception of this article and to the revisions of the manuscript. In addition, all authors approved the final copy of the manuscript. JNS wrote the first draft of the manuscript and drafted the figure.</p>
</fn>
<fn fn-type="conflict" id="fn2-0883073811424796">
<p>The authors declared no potential conflicts of interests with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0883073811424796">
<p>The authors received no financial support for the research and/or authorship of this article. </p>
</fn>
<fn fn-type="other" id="fn4-0883073811424796">
<p>Based on the nature of this article (topical review article), ethical approval from the University of Nebraska Medical Center Institutional Review Board was not necessary.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073811424796">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellison</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Fill</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Terwilliger</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Examination of X chromosome markers in Rett syndrome: exclusion mapping with a novel variation on multilocus linkage analysis</article-title>. <source>Am J Hum Genet</source>. <year>1992</year>;<volume>50</volume>(<issue>2</issue>):<fpage>278</fpage>–<lpage>287</lpage>.</citation>
</ref>
<ref id="bibr2-0883073811424796">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schanen</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Dahle</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Capozzoli</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map</article-title>. <source>Am J Hum Genet</source>. <year>1997</year>;<volume>61</volume>(<issue>3</issue>):<fpage>634</fpage>–<lpage>641</lpage>.</citation>
</ref>
<ref id="bibr3-0883073811424796">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schanen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U</given-names>
</name>
</person-group>. <article-title>A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map</article-title>. <source>Am J Hum Genet</source>. <year>1998</year>;<volume>63</volume>(<issue>1</issue>):<fpage>267</fpage>–<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr4-0883073811424796">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sirianni</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Naidu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28</article-title>. <source>Am J Hum Genet</source>. <year>1998</year>;<volume>63</volume>(<issue>5</issue>):<fpage>1552</fpage>–<lpage>1558</lpage>.</citation>
</ref>
<ref id="bibr5-0883073811424796">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mnatzakanian</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Lohi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Munteanu</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>A previously unidentified <italic>MECP2</italic> open reading frame defines a new protein isoform relevant to Rett syndrome. </article-title>
<source>Nat Genet</source>. <year>2004</year>;<volume>36</volume>(<issue>4</issue>):<fpage>339</fpage>–<lpage>341</lpage>.</citation>
</ref>
<ref id="bibr6-0883073811424796">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Meehan</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2</article-title>. <source>Nucleic Acids Res</source>. <year>1993</year>;<volume>21</volume>(<issue>21</issue>):<fpage>4886</fpage>–<lpage>4892</lpage>.</citation>
</ref>
<ref id="bibr7-0883073811424796">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakefield</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>BO</given-names>
</name>
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>The solution structure of the domain from MeCP2 that binds to methylated DNA</article-title>. <source>J Mol Biol</source>. <year>1999</year>;<volume>291</volume>(<issue>5</issue>):<fpage>1055</fpage>–<lpage>1065</lpage>.</citation>
</ref>
<ref id="bibr8-0883073811424796">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Campoy</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin</article-title>. <source>Cell</source>. <year>1997</year>;<volume>88</volume>(<issue>4</issue>):<fpage>471</fpage>–<lpage>481</lpage>.</citation>
</ref>
<ref id="bibr9-0883073811424796">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Veenstra</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Wade</surname>
<given-names>PA</given-names>
</name>
<etal/>
</person-group>. <article-title>Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription</article-title>. <source>Nat Genet</source>. <year>1998</year>;<volume>19</volume>(<issue>2</issue>):<fpage>187</fpage>–<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr10-0883073811424796">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Meehan</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Henzel</surname>
<given-names>WJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA</article-title>. <source>Cell</source>. <year>1992</year>;<volume>69</volume>(<issue>6</issue>):<fpage>905</fpage>–<lpage>914</lpage>.</citation>
</ref>
<ref id="bibr11-0883073811424796">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tate</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>DNA methylation specifies chromosomal localization of MeCP2</article-title>. <source>Mol Cell Biol</source>. <year>1996</year>;<volume>16</volume>(<issue>1</issue>):<fpage>414</fpage>–<lpage>421</lpage>.</citation>
</ref>
<ref id="bibr12-0883073811424796">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandler</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Guschin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wolffe</surname>
<given-names>AP</given-names>
</name>
</person-group>. <article-title>The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA</article-title>. <source>Biochemistry</source>. <year>1999</year>;<volume>38</volume>(<issue>22</issue>):<fpage>7008</fpage>–<lpage>7018</lpage>.</citation>
</ref>
<ref id="bibr13-0883073811424796">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Jugloff</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells</article-title>. <source>J Neurobiol</source>. <year>2003</year>;<volume>55</volume>(<issue>1</issue>):<fpage>86</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr14-0883073811424796">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>RZ</given-names>
</name>
<name>
<surname>Akbarian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tudor</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice</article-title>. <source>Nat Genet</source>. <year>2001</year>;<volume>27</volume>(<issue>3</issue>):<fpage>327</fpage>–<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr15-0883073811424796">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2</article-title>. <source>Science</source>. <year>2003</year>;<volume>302</volume>(<issue>5646</issue>):<fpage>885</fpage>–<lpage>889</lpage>.</citation>
</ref>
<ref id="bibr16-0883073811424796">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinowich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation</article-title>. <source>Science</source>. <year>2003</year>;<volume>302</volume>(<issue>5646</issue>):<fpage>890</fpage>–<lpage>893</lpage>.</citation>
</ref>
<ref id="bibr17-0883073811424796">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Brain-specific phosphorylation of MeCP2 regulates activity-dependent bdnf transcription, dendritic growth, and spine maturation</article-title>. <source>Neuron</source>. <year>2006</year>;<volume>52</volume>(<issue>2</issue>):<fpage>255</fpage>–<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr18-0883073811424796">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stancheva</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>IB</given-names>
</name>
<etal/>
</person-group>. <article-title>A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos</article-title>. <source>Mol Cell</source>. <year>2003</year>;<volume>12</volume>(<issue>2</issue>):<fpage>425</fpage>–<lpage>435</lpage>.</citation>
</ref>
<ref id="bibr19-0883073811424796">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horike</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miyano</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Loss of silent-chromatin looping and impaired imprinting of<italic> DLX5</italic> in Rett syndrome</article-title>. <source>Nat Genet</source>. <year>2005</year>;<volume>37</volume>(<issue>1</issue>):<fpage>31</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr20-0883073811424796">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peddada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yasui</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>LaSalle</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome</article-title>. <source>Hum Mol Genet</source>. <year>2006</year>;<volume>15</volume>(<issue>12</issue>):<fpage>2003</fpage>–<lpage>2014</lpage>.</citation>
</ref>
<ref id="bibr21-0883073811424796">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nuber</surname>
<given-names>UA</given-names>
</name>
<name>
<surname>Kriaucionis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Roloff</surname>
<given-names>TC</given-names>
</name>
<etal/>
</person-group>. <article-title>Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome</article-title>. <source>Hum Mol Genet</source>. <year>2005</year>;<volume>14</volume>(<issue>15</issue>):<fpage>2247</fpage>–<lpage>2256</lpage>.</citation>
</ref>
<ref id="bibr22-0883073811424796">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itoh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ide</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Takashima</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains</article-title>. <source>J Neuropathol Exp Neurol</source>. <year>2007</year>;<volume>66</volume>(<issue>2</issue>):<fpage>117</fpage>–<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr23-0883073811424796">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kriaucionis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Paterson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome</article-title>. <source>Mol Cell Biol</source>. <year>2006</year>;<volume>26</volume>(<issue>13</issue>):<fpage>5033</fpage>–<lpage>5042</lpage>.</citation>
</ref>
<ref id="bibr24-0883073811424796">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Matagne</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Banine</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice</article-title>. <source>Hum Mol Genet</source>. <year>2007</year>;<volume>16</volume>(<issue>6</issue>):<fpage>640</fpage>–<lpage>650</lpage>.</citation>
</ref>
<ref id="bibr25-0883073811424796">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGill</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Bundle</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Yaylaoglu</surname>
<given-names>MB</given-names>
</name>
<etal/>
</person-group>. <article-title>Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2006</year>;<volume>103</volume>(<issue>48</issue>):<fpage>18267</fpage>–<lpage>18272</lpage>.</citation>
</ref>
<ref id="bibr26-0883073811424796">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samaco</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Hogart</surname>
<given-names>A</given-names>
</name>
<name>
<surname>LaSalle</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Epigenetic overlap in autism-spectrum neurodevelopmental disorders:<italic> MECP2</italic> deficiency causes reduced expression of <italic>UBE3A</italic> and <italic>GABRB3</italic>
</article-title>. <source>Hum Mol Genet</source>. <year>2005</year>;<volume>14</volume>(<issue>4</issue>):<fpage>483</fpage>–<lpage>492</lpage>.</citation>
</ref>
<ref id="bibr27-0883073811424796">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chahrour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>. <article-title>The story of Rett syndrome: from clinic to neurobiology</article-title>. <source>Neuron</source>. <year>2007</year>;<volume>56</volume>(<issue>3</issue>):<fpage>422</fpage>–<lpage>437</lpage>.</citation>
</ref>
<ref id="bibr28-0883073811424796">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagberg</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Rett’s syndrome: prevalence and impact on progressive severe mental retardation in girls</article-title>. <source>Acta Paediatr Scand</source>. <year>1985</year>;<volume>74</volume>(<issue>3</issue>):<fpage>405</fpage>–<lpage>408</lpage>.</citation>
</ref>
<ref id="bibr29-0883073811424796">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imessaoudene</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bonnefont</surname>
<given-names>JP</given-names>
</name>
</person-group>, <article-title>Royer G, et al. <italic>MECP2</italic>
</article-title> <article-title>mutation in non-fatal, non-progressive encephalopathy in a male</article-title>. <source>J Med Genet. 2001;</source>
<volume>38</volume>(<issue>3</issue>):<fpage>171</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr30-0883073811424796">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geerdink</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rotteveel</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Lammens</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>MECP2 mutation in a boy with severe neonatal encephalopathy: clinical, neuropathological and molecular findings</article-title>. <source>Neuropediatrics</source>. <year>2002</year>;<volume>33</volume>(<issue>1</issue>):<fpage>33</fpage>–<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr31-0883073811424796">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armstrong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pineda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aibar</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Classic Rett syndrome in a boy as a result of somatic mosaicism for a <italic>MECP2</italic> mutation</article-title>. <source>Ann Neurol</source>. <year>2001</year>;<volume>50</volume>(<issue>5</issue>):<fpage>692</fpage>.
</citation>
</ref>
<ref id="bibr32-0883073811424796">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budden</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Dorsey</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>RD</given-names>
</name>
</person-group>. <article-title>Clinical profile of a male with Rett syndrome</article-title>. <source>Brain Dev</source>. <year>2005</year>;<volume>27</volume>(<issue>suppl 1</issue>):<fpage>S69</fpage>–<lpage>S71</lpage>.</citation>
</ref>
<ref id="bibr33-0883073811424796">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kankirawatana</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ellaway</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Early progressive encephalopathy in boys and <italic>MECP2</italic> mutations</article-title>. <source>Neurology</source>. <year>2006</year>;<volume>67</volume>(<issue>1</issue>):<fpage>164</fpage>–<lpage>166</lpage>.</citation>
</ref>
<ref id="bibr34-0883073811424796">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leonard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Silberstein</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Falk</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Occurrence of Rett syndrome in boys</article-title>. <source>J Child Neurol</source>. <year>2001</year>;<volume>16</volume>(<issue>5</issue>):<fpage>333</fpage>–<lpage>338</lpage>.</citation>
</ref>
<ref id="bibr35-0883073811424796">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leuzzi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Di Sabato</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Zollino</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Early-onset encephalopathy and cortical myoclonus in a boy with <italic>MECP2</italic> gene mutation</article-title>. <source>Neurology</source>. <year>2004</year>;<volume>63</volume>(<issue>10</issue>):<fpage>1968</fpage>–<lpage>1970</lpage>.</citation>
</ref>
<ref id="bibr36-0883073811424796">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundvall</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Samuelsson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kyllerman</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Male Rett phenotypes in T158M and R294X MeCP2-mutations</article-title>. <source>Neuropediatrics</source>. <year>2006</year>;<volume>37</volume>(<issue>5</issue>):<fpage>296</fpage>–<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr37-0883073811424796">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masuyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Matsuo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>JJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Classic Rett syndrome in a boy with R133C mutation of <italic>MECP2</italic>
</article-title>. <source>Brain Dev</source>. <year>2005</year>;<volume>27</volume>(<issue>6</issue>):<fpage>439</fpage>–<lpage>442</lpage>.</citation>
</ref>
<ref id="bibr38-0883073811424796">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rett</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>On a unusual brain atrophy syndrome in hyperammonemia in childhood</article-title>. <source>Wien Med Wochenschr</source>. <year>1966</year>;<volume>116</volume>(<issue>37</issue>):<fpage>723</fpage>–<lpage>726</lpage>.</citation>
</ref>
<ref id="bibr39-0883073811424796">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Aicardi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>O. A</given-names>
</name>
</person-group> <article-title>progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls</article-title>: <article-title>Rett’s syndrome: report of 35 cases</article-title>. <source>Ann Neurol</source>. <year>1983</year>;<volume>14</volume>(<issue>4</issue>):<fpage>471</fpage>–<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr40-0883073811424796">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trevathan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Naidu</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>The clinical recognition and differential diagnosis of Rett syndrome</article-title>. <source>J Child Neurol</source>. <year>1988</year>;<volume>3</volume>(<issue>suppl</issue>):<fpage>S6</fpage>–<lpage>S16</lpage>.</citation>
</ref>
<ref id="bibr41-0883073811424796">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hanefeld</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Skjeldal</surname>
<given-names>O</given-names>
</name>
</person-group>. <article-title>An update on clinically applicable diagnostic criteria in Rett syndrome: comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting</article-title>, <source>Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol</source>. <year>2002</year>;<volume>6</volume>(<issue>5</issue>):<fpage>293</fpage>–<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr42-0883073811424796">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome is caused by mutations in X-linked <italic>MECP2</italic>, encoding methyl-CpG-binding protein 2</article-title>. <source>Nat Genet</source>. <year>1999</year>;<volume>23</volume>(<issue>2</issue>):<fpage>185</fpage>–<lpage>188</lpage>.</citation>
</ref>
<ref id="bibr43-0883073811424796">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bienvenu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Carrie</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Roux</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>MECP2 mutations account for most cases of typical forms of Rett syndrome</article-title>. <source>Hum Mol Genet</source>. <year>2000</year>;<volume>9</volume>(<issue>9</issue>):<fpage>1377</fpage>–<lpage>1384</lpage>.</citation>
</ref>
<ref id="bibr44-0883073811424796">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smeets</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Terhal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Casaer</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome in females with CTS hot spot deletions: a disorder profile</article-title>. <source>Am J Med Genet A</source>. <year>2005</year>;<volume>132</volume>(<issue>2</issue>):<fpage>117</fpage>–<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr45-0883073811424796">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourdon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Labrune</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>A detailed analysis of the <italic>MECP2</italic> gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients</article-title>. <source>Hum Genet</source>. <year>2001</year>;<volume>108</volume>(<issue>1</issue>):<fpage>43</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr46-0883073811424796">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hampson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Woods</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Latif</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Mutations in the <italic>MECP2</italic> gene in a cohort of girls with Rett syndrome</article-title>. <source>J Med Genet</source>. <year>2000</year>;<volume>37</volume>(<issue>8</issue>):<fpage>610</fpage>–<lpage>612</lpage>.</citation>
</ref>
<ref id="bibr47-0883073811424796">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kammoun</surname>
<given-names>F</given-names>
</name>
<name>
<surname>de Roux</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Boespflug-Tanguy</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Screening of<italic> MECP2</italic> coding sequence in patients with phenotypes of decreasing likelihood for Rett syndrome: a cohort of 171 cases</article-title>. <source>J Med Genet</source>. <year>2004</year>;<volume>41</volume>(<issue>6</issue>):<fpage>e85</fpage>.</citation>
</ref>
<ref id="bibr48-0883073811424796">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Junemann</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Whatley</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Large deletions of the <italic>MECP2</italic> gene detected by gene dosage analysis in patients with Rett syndrome</article-title>. <source>Hum Mutat</source>. <year>2004</year>;<volume>23</volume>(<issue>3</issue>):<fpage>234</fpage>–<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr49-0883073811424796">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Huppke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hanefeld</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Meins</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Mutation spectrum in patients with Rett syndrome in the German population: evidence of hot spot regions</article-title>. <source>Hum Mutat</source>. <year>2001</year>;<volume>17</volume>(<issue>3</issue>):<fpage>183</fpage>–<lpage>190</lpage>.</citation>
</ref>
<ref id="bibr50-0883073811424796">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miltenberger-Miltenyi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Mutations and polymorphisms in the human methyl CpG-binding protein <italic>MECP2</italic></article-title>. <source>Hum Mutat</source>. <year>2003</year>; <volume>22</volume>(<issue>2</issue>):<fpage>107</fpage>–<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr51-0883073811424796">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Buervenich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nicolao</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutation screening in Rett syndrome patients</article-title>. <source>J Med Genet</source>. <year>2000</year>;<volume>37</volume>(<issue>4</issue>):<fpage>250</fpage>–<lpage>255</lpage>.</citation>
</ref>
<ref id="bibr52-0883073811424796">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsuishi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutation analysis of the methyl-CpG binding protein 2 gene (<italic>MECP2</italic>) in patients with Rett syndrome</article-title>. <source>J Med Genet</source>. <year>2000</year>;<volume>37</volume>(<issue>8</issue>):<fpage>608</fpage>–<lpage>610</lpage>.</citation>
</ref>
<ref id="bibr53-0883073811424796">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Percy</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>JB</given-names>
</name>
</person-group>. <article-title>Rett syndrome: clinical and molecular update</article-title>. <source>Curr Opin Pediatr</source>. <year>2004</year>;<volume>16</volume>(<issue>6</issue>):<fpage>670</fpage>–<lpage>677</lpage>.</citation>
</ref>
<ref id="bibr54-0883073811424796">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zappella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Preserved speech variants of the Rett syndrome: molecular and clinical analysis</article-title>. <source>Am J Med Genet</source>. <year>2001</year>;<volume>104</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr55-0883073811424796">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klauck</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Lindsay</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Beyer</surname>
<given-names>KS</given-names>
</name>
<etal/>
</person-group>. <article-title>A mutation hot spot for nonspecific X-linked mental retardation in the <italic>MECP2</italic> gene causes the PPM-X syndrome</article-title>. <source>Am J Hum Genet</source>. <year>2002</year>;<volume>70</volume>(<issue>4</issue>):<fpage>1034</fpage>–<lpage>1037</lpage>.</citation>
</ref>
<ref id="bibr56-0883073811424796">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yaron</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ben Zeev</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Shomrat</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>MECP2 mutations in Israel: implications for molecular analysis, genetic counseling, and prenatal diagnosis in Rett syndrome</article-title>. <source>Hum Mutat</source>. <year>2002</year>;<volume>20</volume>(<issue>4</issue>):<fpage>323</fpage>–<lpage>324</lpage>.</citation>
</ref>
<ref id="bibr57-0883073811424796">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schollen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Smeets</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Deflem</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Gross rearrangements in the <italic>MECP2</italic> gene in three patients with Rett syndrome: implications for routine diagnosis of Rett syndrome</article-title>. <source>Hum Mutat</source>. 2003;<volume>22</volume>(<issue>2</issue>):<fpage>116</fpage>–<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr58-0883073811424796">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erlandson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Samuelsson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hagberg</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the <italic>MECP2</italic> gene of Swedish Rett syndrome patients</article-title>. <source>Genet Test</source>. <year>2003</year>;<volume>7</volume>(<issue>4</issue>):<fpage>329</fpage>–<lpage>332</lpage>.</citation>
</ref>
<ref id="bibr59-0883073811424796">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ariani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mari</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pescucci</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: report of one case of <italic>MECP2</italic> deletion and one case of MECP2 duplication</article-title>. <source>Hum Mutat</source>. <year>2004</year>;<volume>24</volume>(<issue>2</issue>):<fpage>172</fpage>–<lpage>177</lpage>.</citation>
</ref>
<ref id="bibr60-0883073811424796">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravn</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Skjeldal</surname>
<given-names>OH</given-names>
</name>
<etal/>
</person-group>. <article-title>Large genomic rearrangements in <italic>MECP2</italic>
</article-title>. <source>Hum Mutat</source>. <year>2005</year>;<volume>25</volume>(<issue>3</issue>):<fpage>324</fpage>.</citation>
</ref>
<ref id="bibr61-0883073811424796">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huppke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ohlenbusch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brendel</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutation analysis of the<italic> HDAC</italic> 1, 2, 8 and <italic>CDKL5</italic> genes in Rett syndrome patients without mutations in <italic>MECP2</italic>
</article-title>. <source>Am J Med Genet A</source>. <year>2005</year>;<volume>137</volume>(<issue>2</issue>):<fpage>136</fpage>–<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr62-0883073811424796">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shibayama</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Detection of heterozygous deletions and duplications in the <italic>MECP2</italic> gene in Rett syndrome by robust dosage PCR (RD-PCR)</article-title>. <source>Hum Mutat</source>. <year>2005</year>;<volume>25</volume>(<issue>5</issue>):<fpage>505</fpage>.</citation>
</ref>
<ref id="bibr63-0883073811424796">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Archer</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Whatley</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>Gross rearrangements of the <italic>MECP2</italic> gene are found in both classical and atypical Rett syndrome patients</article-title>. <source>J Med Genet</source>. <year>2006</year>;<volume>43</volume>(<issue>5</issue>):<fpage>451</fpage>–<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr64-0883073811424796">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scala</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ottimo</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>MECP2 deletions and genotype-phenotype correlation in Rett syndrome</article-title>. <source>Am J Med Genet A</source>. <year>2007</year>;<volume>143</volume>(<issue>23</issue>):<fpage>2775</fpage>–<lpage>2784</lpage>.</citation>
</ref>
<ref id="bibr65-0883073811424796">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardwick</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Reuter</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>SL</given-names>
</name>
<etal/>
</person-group>. <article-title>Delineation of large deletions of the <italic>MECP2</italic> gene in Rett syndrome patients, including a familial case with a male proband</article-title>. <source>Eur J Hum Genet</source>. <year>2007</year>;<volume>15</volume>(<issue>12</issue>):<fpage>1218</fpage>–<lpage>1229</lpage>.</citation>
</ref>
<ref id="bibr66-0883073811424796">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lachlan</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Collinson</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Sandford</surname>
<given-names>RO</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional disomy resulting from duplications of distal Xq in four unrelated patients</article-title>. <source>Hum Genet</source>. <year>2004</year>;<volume>115</volume>(<issue>5</issue>):<fpage>399</fpage>–<lpage>408</lpage>.</citation>
</ref>
<ref id="bibr67-0883073811424796">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>YC</given-names>
</name>
</person-group>
<etal/>. <article-title>Primary ovarian failure in a mentally retarded woman with a de novo unbalanced X;autosome translocation</article-title>. <source>Fertil Steril</source>. <year>2006</year>;<volume>86</volume>(<issue>5</issue>):1514.<fpage>e1</fpage>–<lpage>1514</lpage>.e2.</citation>
</ref>
<ref id="bibr68-0883073811424796">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merhi</surname>
<given-names>ZO</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Awonuga</surname>
<given-names>AO</given-names>
</name>
</person-group>. <article-title>A case of 46,X,der(X) t(X;X)(q22.1;p11) Xq22.1→Xqter in a 12-year-old girl with premature ovarian failure</article-title>. <source>Gynecol Obstet Invest</source>. <year>2007</year>;<volume>63</volume>(<issue>3</issue>):<fpage>137</fpage>–<lpage>139</lpage>.</citation>
</ref>
<ref id="bibr69-0883073811424796">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Portnoi</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Aboura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tachdjian</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients</article-title>. <source>Hum Reprod</source>. <year>2006</year>;<volume>21</volume>(<issue>9</issue>):<fpage>2329</fpage>–<lpage>2334</lpage>.</citation>
</ref>
<ref id="bibr70-0883073811424796">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prueitt</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Zinn</surname>
<given-names>AR</given-names>
</name>
</person-group>. <article-title>Most X;autosome translocations associated with premature ovarian failure do not interrupt X-linked genes</article-title>. <source>Cytogenet Genome Res</source>. <year>2002</year>;<volume>97</volume>(<issue>1-2</issue>):<fpage>32</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr71-0883073811424796">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossetti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rizzolio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pramparo</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28</article-title>. <source>Eur J Hum Genet</source>. <year>2004</year>;<volume>12</volume>(<issue>10</issue>):<fpage>829</fpage>–<lpage>834</lpage>.</citation>
</ref>
<ref id="bibr72-0883073811424796">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eggermann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Meschede</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schuler</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Premature ovarian failure associated with a small terminal Xq deletion: narrowing the POF1 region down to Xq27.2/Xq27.3-qter</article-title>. <source>Clin Genet</source>. <year>2005</year>;<volume>67</volume>(<issue>5</issue>):<fpage>434</fpage>–<lpage>437</lpage>.</citation>
</ref>
<ref id="bibr73-0883073811424796">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armstrong</surname>
<given-names>DD</given-names>
</name>
</person-group>. <article-title>Rett syndrome neuropathology review 2000</article-title>. <source>Brain Dev</source>. <year>2001</year>;<volume>23</volume>(<issue>suppl 1</issue>):<fpage>S72</fpage>–<lpage>S76</lpage>.</citation>
</ref>
<ref id="bibr74-0883073811424796">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartzman</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Bernardino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome in a boy with a 47, XXY karyotype confirmed by a rare mutation in the <italic>MECP2</italic> gene</article-title>. <source>Neuropediatrics</source>. <year>2001</year>;<volume>32</volume>(<issue>3</issue>):<fpage>162</fpage>–<lpage>164</lpage>.</citation>
</ref>
<ref id="bibr75-0883073811424796">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yntema</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Nillesen</surname>
<given-names>WM</given-names>
</name>
<etal/>
</person-group>. <italic>MECP2</italic> <article-title>analysis in mentally retarded patients: implications for routine DNA diagnostics</article-title>. <source>Eur J Hum Genet</source>. <year>2004</year>;<volume>12</volume>(<issue>1</issue>):<fpage>24</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr76-0883073811424796">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots</article-title>. <source>Am J Hum Genet</source>. <year>1999</year>;<volume>65</volume>(<issue>6</issue>):<fpage>1520</fpage>–<lpage>1529</lpage>.</citation>
</ref>
<ref id="bibr77-0883073811424796">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villard</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kpebe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chelly</surname>
<given-names>PJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Two affected boys in a Rett syndrome family: clinical and molecular findings</article-title>. <source>Neurology</source>. <year>2000</year>;<volume>55</volume>(<issue>8</issue>):<fpage>1188</fpage>–<lpage>1193</lpage>.</citation>
</ref>
<ref id="bibr78-0883073811424796">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeev</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Yaron</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Schanen</surname>
<given-names>NC</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome: clinical manifestations in males with <italic>MECP2</italic> mutations</article-title>. <source>J Child Neurol</source>. <year>2002</year>;<volume>17</volume>(<issue>1</issue>):<fpage>20</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr79-0883073811424796">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffbuhr</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Devaney</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>LaFleur</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>MeCP2 mutations in children with and without the phenotype of Rett syndrome</article-title>. <source>Neurology</source>. <year>2001</year>;<volume>56</volume>(<issue>11</issue>):<fpage>1486</fpage>–<lpage>1495</lpage>.</citation>
</ref>
<ref id="bibr80-0883073811424796">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravn</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Uldall</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>No correlation between phenotype and genotype in boys with a truncating <italic>MECP2</italic> mutation</article-title>. <source>J Med Genet</source>. <year>2003</year>;<volume>40</volume>(<issue>1</issue>):<fpage>e5</fpage>.</citation>
</ref>
<ref id="bibr81-0883073811424796">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clayton-Smith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ramsden</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>GC</given-names>
</name>
</person-group>. <article-title>Somatic mutation in <italic>MECP2</italic> as a non-fatal neurodevelopmental disorder in males</article-title>. <source>Lancet</source>. <year>2000</year>;<volume>356</volume>(<issue>9232</issue>):<fpage>830</fpage>–<lpage>832</lpage>.</citation>
</ref>
<ref id="bibr82-0883073811424796">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Topcu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Akyerli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sayi</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Somatic mosaicism for a<italic> MECP2</italic> mutation associated with classic Rett syndrome in a boy</article-title>. <source>Eur J Hum Genet</source>. <year>2002</year>;<volume>10</volume>(<issue>1</issue>):<fpage>77</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr83-0883073811424796">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dayer</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Bottani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bouchardy</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>
<article-title>.<italic> MECP2</italic> mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother</article-title>. <source>Brain Dev</source>. <year>2007</year>;<volume>29</volume>(<issue>1</issue>):<fpage>47</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr84-0883073811424796">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meloni</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bruttini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>A mutation in the Rett syndrome gene, <italic>MECP2</italic>, causes X-linked mental retardation and progressive spasticity in males</article-title>. <source>Am J Hum Genet</source>. <year>2000</year>;<volume>67</volume>(<issue>4</issue>):<fpage>982</fpage>–<lpage>985</lpage>.</citation>
</ref>
<ref id="bibr85-0883073811424796">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Couvert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bienvenu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aquaviva</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title><italic>MECP2</italic> is highly mutated in X-linked mental retardation</article-title>. <source>Hum Mol Genet</source>. <year>2001</year>;<volume>10</volume>(<issue>9</issue>):<fpage>941</fpage>–<lpage>946</lpage>.</citation>
</ref>
<ref id="bibr86-0883073811424796">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orrico</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title><italic>MECP2</italic> mutation in male patients with non-specific X-linked mental retardation</article-title>. <source>FEBS Lett</source>. <year>2000</year>;<volume>481</volume>(<issue>3</issue>):<fpage>285</fpage>–<lpage>288</lpage>.</citation>
</ref>
<ref id="bibr87-0883073811424796">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jedele</surname>
<given-names>KB</given-names>
</name>
</person-group>. <article-title>The overlapping spectrum of Rett and Angelman syndromes: a clinical review</article-title>. <source>Semin Pediatr Neurol</source>. <year>2007</year>;<volume>14</volume>(<issue>3</issue>):<fpage>108</fpage>–<lpage>117</lpage>.</citation>
</ref>
<ref id="bibr88-0883073811424796">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ramsden</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Angelman syndrome phenotype associated with mutations in <italic>MECP2</italic>, a gene encoding a methyl CpG binding protein</article-title>. <source>J Med Genet</source>. <year>2001</year>;<volume>38</volume>(<issue>4</issue>):<fpage>224</fpage>–<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr89-0883073811424796">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lev-Lehman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bressler</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Genetics of Angelman syndrome</article-title>. <source>Am J Hum Genet</source>. <year>1999</year>;<volume>65</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr90-0883073811424796">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yntema</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oudakker</surname>
<given-names>AR</given-names>
</name>
<etal/>
</person-group>. <article-title>Low frequency of<italic> MECP2</italic> mutations in mentally retarded males</article-title>. <source>Eur J Hum Genet</source>. <year>2002</year>;<volume>10</volume>(<issue>8</issue>):<fpage>487</fpage>–<lpage>490</lpage>.</citation>
</ref>
<ref id="bibr91-0883073811424796">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yntema</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Oudakker</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>In-frame deletion in <italic>MECP2</italic> causes mild nonspecific mental retardation</article-title>. <source>Am J Med Genet</source>. <year>2002</year>;<volume>107</volume>(<issue>1</issue>):<fpage>81</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr92-0883073811424796">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourdon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title><italic>MECP2</italic> mutations or polymorphisms in mentally retarded boys: diagnostic implications</article-title>. <source>Mol Diagn</source>. <year>2003</year>;<volume>7</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr93-0883073811424796">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harvey</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Stachowiak</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Sequence variants within exon 1 of <italic>MECP2</italic> occur in females with mental retardation</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. <year>2007</year>;<volume>144</volume>(<issue>3</issue>):<fpage>355</fpage>–<lpage>360</lpage>.</citation>
</ref>
<ref id="bibr94-0883073811424796">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkmar</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Pauls</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Autism</article-title>. <source>Lancet</source>. <year>2003</year>;<volume>362</volume>(<issue>9390</issue>):<fpage>1133</fpage>–<lpage>1141</lpage>.</citation>
</ref>
<ref id="bibr95-0883073811424796">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>CH</given-names>
</name>
<etal/>
</person-group>. <article-title>Spectrum of mutations in the <italic>MECP2</italic> gene in patients with infantile autism and Rett syndrome</article-title>. <source>J Med Genet</source>. <year>2000</year>;<volume>37</volume>(<issue>12</issue>):<fpage>E41</fpage>.</citation>
</ref>
<ref id="bibr96-0883073811424796">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carney</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Wolpert</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Ravan</surname>
<given-names>SA</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of MeCP2 mutations in a series of females with autistic disorder</article-title>. <source>Pediatr Neurol</source>. <year>2003</year>;<volume>28</volume>(<issue>3</issue>):<fpage>205</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr97-0883073811424796">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zappella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Study of <italic>MECP2</italic> gene in Rett syndrome variants and autistic girls</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. <year>2003</year>;<volume>119</volume>(<issue>1</issue>):<fpage>102</fpage>–<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr98-0883073811424796">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibayama</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. <year>2004</year>;<volume>128</volume>(<issue>1</issue>):<fpage>50</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr99-0883073811424796">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coutinho</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title><italic>MECP2</italic> coding sequence and 3′UTR variation in 172 unrelated autistic patients</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. <year>2007</year>;<volume>144</volume>(<issue>4</issue>):<fpage>475</fpage>–<lpage>483</lpage>.</citation>
</ref>
<ref id="bibr100-0883073811424796">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdul-Rahman</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Hudgins</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>The diagnostic utility of a genetics evaluation in children with pervasive developmental disorders</article-title>. <source>Genet Med</source>. <year>2006</year>;<volume>8</volume>(<issue>1</issue>):<fpage>50</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr101-0883073811424796">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Newton</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Genetic aspects of cerebral palsy</article-title>. <source>Dev Med Child Neurol</source>. <year>1992</year>;<volume>34</volume>(<issue>1</issue>):<fpage>80</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr102-0883073811424796">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adler</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Familial cerebral palsy</article-title>. <source>J Chronic Dis</source>. <year>1961</year>;<volume>13</volume>:<fpage>207</fpage>–<lpage>214</lpage>.</citation>
</ref>
<ref id="bibr103-0883073811424796">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bundey</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>MI</given-names>
</name>
</person-group>. <article-title>Recurrence risks in families of children with symmetrical spasticity</article-title>. <source>Dev Med Child Neurol</source>. <year>1977</year>;<volume>19</volume>(<issue>2</issue>):<fpage>179</fpage>–<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr104-0883073811424796">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petterson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Cerebral palsy in multiple births in Western Australia: genetic aspects</article-title>. <source>Am J Med Genet</source>. <year>1990</year>;<volume>37</volume>(<issue>3</issue>):<fpage>346</fpage>–<lpage>351</lpage>.</citation>
</ref>
<ref id="bibr105-0883073811424796">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laplaza</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Root</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tassanawipas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cervera</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Cerebral palsy in twins</article-title>. <source>Dev Med Child Neurol</source>. <year>1992</year>;<volume>34</volume>(<issue>12</issue>):<fpage>1053</fpage>–<lpage>1063</lpage>.</citation>
</ref>
<ref id="bibr106-0883073811424796">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fletcher</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Parental age, genetic mutation, and cerebral palsy</article-title>. <source>J Med Genet</source>. <year>1993</year>;<volume>30</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr107-0883073811424796">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bundey</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Symmetry of neurological signs in Pakistani patients with probable inherited spastic cerebral palsy</article-title>. <source>Clin Genet</source>. <year>1997</year>;<volume>51</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr108-0883073811424796">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaefer</surname>
<given-names>GB</given-names>
</name>
</person-group>. <article-title>Genetics considerations in cerebral palsy</article-title>. <source>Semin Pediatr Neurol</source>. <year>2008</year>;<volume>15</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr109-0883073811424796">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Levenson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Vilaythong</surname>
<given-names>AP</given-names>
</name>
<etal/>
</person-group>. <article-title>Mild overexpression of MeCP2 causes a progressive neurological disorder in mice</article-title>. <source>Hum Mol Genet</source>. <year>2004</year>;<volume>13</volume>(<issue>21</issue>):<fpage>2679</fpage>–<lpage>2689</lpage>.</citation>
</ref>
<ref id="bibr110-0883073811424796">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>del Gaudio</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Scaglia</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Increased <italic>MECP2</italic> gene copy number as the result of genomic duplication in neurodevelopmentally delayed males</article-title>. <source>Genet Med</source>. <year>2006</year>;<volume>8</volume>(<issue>12</issue>):<fpage>784</fpage>–<lpage>792</lpage>.</citation>
</ref>
<ref id="bibr111-0883073811424796">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friez</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Clarkson</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Recurrent infections, hypotonia, and mental retardation caused by duplication of<italic> MECP2</italic> and adjacent region in Xq28</article-title>. <source>Pediatrics</source>. <year>2006</year>;<volume>118</volume>(<issue>6</issue>):<fpage>e1687</fpage>–<lpage>e1695</lpage>.</citation>
</ref>
<ref id="bibr112-0883073811424796">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Esch</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauters</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ignatius</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Duplication of the <italic>MECP2</italic> region is a frequent cause of severe mental retardation and progressive neurological symptoms in males</article-title>. <source>Am J Hum Genet</source>. <year>2005</year>;<volume>77</volume>(<issue>3</issue>):<fpage>442</fpage>–<lpage>453</lpage>.</citation>
</ref>
<ref id="bibr113-0883073811424796">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meins</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gerresheim</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Submicroscopic duplication in Xq28 causes increased expression of the <italic>MECP2</italic> gene in a boy with severe mental retardation and features of Rett syndrome</article-title>. <source>J Med Genet</source>. <year>2005</year>;<volume>42</volume>(<issue>2</issue>):<fpage>e12</fpage>.</citation>
</ref>
<ref id="bibr114-0883073811424796">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lugtenberg</surname>
<given-names>D</given-names>
</name>
<name>
<surname>de Brouwer</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH</article-title>. <source>J Med Genet</source>. <year>2006</year>;<volume>43</volume>(<issue>4</issue>):<fpage>362</fpage>–<lpage>370</lpage>.</citation>
</ref>
<ref id="bibr115-0883073811424796">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanlaville</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Prieur</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de Blois</surname>
<given-names>MC</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional disomy of the Xq28 chromosome region</article-title>. <source>Eur J Hum Genet</source>. <year>2005</year>;<volume>13</volume>(<issue>5</issue>):<fpage>579</fpage>–<lpage>585</lpage>.</citation>
</ref>
<ref id="bibr116-0883073811424796">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahn</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Breg</surname>
<given-names>WR</given-names>
</name>
<etal/>
</person-group>. <article-title>Xq-yq interchange resulting in supernormal X-linked gene expression in severely retarded males with 46,XYq-karyotype</article-title>. <source>Nat Genet</source>. <year>1994</year>;<volume>8</volume>(<issue>3</issue>):<fpage>243</fpage>–<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr117-0883073811424796">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lammer</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Punglia</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>AE</given-names>
</name>
<etal/>
</person-group>. <article-title>Inherited duplication of Xq27.2→qter: phenocopy of infantile Prader-Willi syndrome</article-title>. <source>Clin Dysmorphol</source>. <year>2001</year>;<volume>10</volume>(<issue>2</issue>):<fpage>141</fpage>–<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr118-0883073811424796">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Rutberg</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Inherited duplication Xq27-qter at Xp22.3 in severely affected males: molecular cytogenetic evaluation and clinical description in three unrelated families</article-title>. <source>Am J Med Genet</source>. <year>1998</year>;<volume>80</volume>(<issue>4</issue>):<fpage>377</fpage>–<lpage>384</lpage>.</citation>
</ref>
<ref id="bibr119-0883073811424796">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akiyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kawame</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohashi</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional disomy for Xq26.3-qter in a boy with an unbalanced t(X;21)(q26.3;p11.2) translocation</article-title>. <source>Am J Med Genet</source>. <year>2001</year>;<volume>99</volume>(<issue>2</issue>):<fpage>111</fpage>–<lpage>114</lpage>.</citation>
</ref>
<ref id="bibr120-0883073811424796">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasquez</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bobadilla</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Crolla</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>A familial xp+ chromosome, dup (Xq26.3→qter)</article-title>. <source>J Med Genet</source>. <year>1995</year>;<volume>32</volume>(<issue>11</issue>):<fpage>891</fpage>–<lpage>893</lpage>.</citation>
</ref>
<ref id="bibr121-0883073811424796">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kokalj-Vokac</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Marcun-Varda</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zagorac</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Subterminal deletion/duplication event in an affected male due to maternal X chromosome pericentric inversion</article-title>. <source>Eur J Pediatr</source>. <year>2004</year>;<volume>163</volume>(<issue>11</issue>):<fpage>658</fpage>–<lpage>663</lpage>.</citation>
</ref>
<ref id="bibr122-0883073811424796">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bernardini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Salpietro</surname>
<given-names>DC</given-names>
</name>
<etal/>
</person-group>. <article-title>Disomy of distal Xq in males: case report and overview</article-title>. <source>Am J Med Genet A</source>. <year>2004</year>;<volume>128</volume>(<issue>2</issue>):<fpage>165</fpage>–<lpage>169</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>